Edition:
United States

Hansa Medical AB (HMED.ST)

HMED.ST on Stockholm Stock Exchange

277.20SEK
8:04am EST
Change (% chg)

0.60kr (+0.22%)
Prev Close
276.60kr
Open
275.20kr
Day's High
280.00kr
Day's Low
274.60kr
Volume
59,093
Avg. Vol
195,238
52-wk High
349.40kr
52-wk Low
195.00kr

Latest Key Developments (Source: Significant Developments)

Hansa Medical: SEK 453 Mln Before Issue Costs In New Issue
Tuesday, 13 Nov 2018 07:15pm EST 

Nov 14 (Reuters) - Hansa Medical AB ::ANNOUNCED ON WEDNESDAY CLOSING OF DIRECTED SHARE ISSUE CONSISTING OF 1,776,765 ORDINARY SHARES AT PRICE OF SEK 255 PER SHARE.SHARE ISSUE WILL RAISE PROCEEDS TO THE COMPANY OF SEK 453 / $50 MILLION BEFORE ISSUE COSTS.SHARE ISSUE WAS SIGNIFICANTLY OVERSUBSCRIBED DUE TO HIGH DEMAND FROM US, UK, SWISS AND SWEDISH INSTITUTIONAL INVESTORS INCLUDING CONSONANCE CAPITAL, REDMILE GROUP, POLAR CAPITAL AND HBM PARTNERS.IN CONNECTION WITH SHARE ISSUE, CO'S LARGEST SHAREHOLDER NEXTTOBE SOLD PART OF STAKE CORRESPONDING TO 888,382 ORDINARY SHARES IN HANSA MEDICAL AT THE SAME PRICE AS THE SHARE ISSUE.  Full Article

Hansa Medical Q3 Operating Loss Widens To SEK 60.5 Mln
Thursday, 1 Nov 2018 03:00am EDT 

Nov 1 (Reuters) - Hansa Medical AB ::Q3 NET REVENUE SEK 0.5 MILLION VERSUS SEK 0.7 MILLION YEAR AGO.Q3 OPERATING LOSS SEK 60.5 MILLION VERSUS LOSS SEK 37.4 MILLION YEAR AGO.  Full Article

Hansa Medical Appoints Søren Tulstrup New President And CEO
Tuesday, 20 Mar 2018 07:00am EDT 

March 20 (Reuters) - HANSA MEDICAL AB ::SØREN TULSTRUP APPOINTED NEW PRESIDENT AND CEO OF HANSA MEDICAL.‍ACTING CEO ULF WIINBERG REVERTS TO HIS FORMER ROLE AS CHAIRMAN OF HANSA MEDICAL​.‍BIRGIT STATTIN NORINDER REVERTS TO HER FORMER ROLE AS MEMBER OF BOARD OF DIRECTORS.​.APPOINTED SØREN TULSTRUP AS NEW PRESIDENT AND CEO OF HANSA MEDICAL EFFECTIVE TODAY MARCH 20, 2018​.‍SØREN TULSTRUP RECENTLY SERVED AS CEO OF VIFOR PHARMA AG​.  Full Article

Hansa Medical Granted Orphan Drug Designation By FDA
Friday, 16 Feb 2018 03:45am EST 

Feb 16 (Reuters) - HANSA MEDICAL AB ::HANSA MEDICAL RECEIVES FDA ORPHAN DRUG DESIGNATION FOR IDES AND THE TREATMENT OF GUILLAIN-BARRÉ SYNDROME.  Full Article

Hansa Medical AB Q4 Net Revenue Sek 1.0 ‍​ Million Versus Sek 0.5 Million Year Ago
Wednesday, 14 Feb 2018 02:00am EST 

Feb 14 (Reuters) - HANSA MEDICAL AB ::Q4 NET REVENUE SEK 1.0 ‍​ MILLION VERSUS SEK 0.5 MILLION YEAR AGO.Q4 OPERATING LOSS SEK ‍​ 48.9 MILLION VERSUS LOSS SEK 33.6 MILLION YEAR AGO.  Full Article

‍Hansa Medical Contemplates Directed Share Issue To Raise About Sek 545 mln​
Wednesday, 29 Nov 2017 11:30am EST 

Nov 29 (Reuters) - Hansa Medical Ab ::‍HANSA MEDICAL CONTEMPLATES A DIRECTED SHARE ISSUE TO RAISE APPROXIMATELY SEK 545 MILLION​.HANSA MEDICAL -COMMISSIONED EVERCORE, RBC CAPITAL AND SEB, TO INVESTIGATE POSSIBILITY OF UNDERTAKING NEW ISSUE OF SHARES TO INSTITUTIONAL INVESTORS.‍INTENDS TO USE PROCEEDS FROM DIRECTED ISSUE TO FUND CONTINUED DEVELOPMENT OF COMPANY'S EXISTING PORTFOLIO​.  Full Article

Hansa Medical Q3 operating loss up at SEK ‍​37.4 mln
Tuesday, 14 Nov 2017 02:00am EST 

Nov 14 (Reuters) - HANSA MEDICAL AB ::Q3 OPERATING LOSS SEK ‍​37.4 MILLION VERSUS LOSS SEK 27.0 MILLION YEAR AGO.Q3 NET REVENUE SEK ‍​678,000 VERSUS SEK 0.9 MILLION YEAR AGO.  Full Article

Hansa Medical: sudden death of CEO Göran Arvidson​
Wednesday, 8 Nov 2017 02:00am EST 

Nov 8 (Reuters) - HANSA MEDICAL AB :‍ANNOUNCES SUDDEN DEATH OF CEO GÖRAN ARVIDSON​.‍CHAIRMAN ULF WIINBERG WILL SERVE AS ACTING CEO.‍BIRGIT STATTIN NORINDER WILL TAKE OVER ROLE AS CHAIRMAN OF BOARD UNTIL FURTHER NOTICE​.  Full Article

Hansa Medical Q2 operating loss at SEK 44.9 million
Thursday, 20 Jul 2017 02:00am EDT 

July 20 (Reuters) - HANSA MEDICAL AB :Q2 NET REVENUE SEK 0.7 MILLION VERSUS SEK 0.5 MILLION YEAR AGO.Q2 OPERATING LOSS SEK 44.9 MILLION VERSUS LOSS SEK 30.7 MILLION YEAR AGO.  Full Article

Hansa Medical Q1 net sales rise to sek 1.1 million
Wednesday, 26 Apr 2017 02:00am EDT 

April 26 (Reuters) - HANSA MEDICAL AB ::Q1 NET SALES SEK 1.1 MILLION VERSUS SEK 0.6 MILLION YEAR AGO.Q1 OPERATING LOSS SEK 44.8 MILLION VERSUS LOSS SEK 19.9 MILLION YEAR AGO.  Full Article

BRIEF-Hansa Medical: SEK 453 Mln Before Issue Costs In New Issue

* ANNOUNCED ON WEDNESDAY CLOSING OF DIRECTED SHARE ISSUE CONSISTING OF 1,776,765 ORDINARY SHARES AT PRICE OF SEK 255 PER SHARE